Medical Innovation Acceleration Act of 2023
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jan 9, 2023)
Medical Innovation Acceleration Act of 2023
This bill exempts noninvasive diagnostic devices from the regulatory authority of the Food and Drug Administration.
The bill defines noninvasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.
What just happenedJan 9, 2023
Referred to the House Committee on Energy and Commerce.
Who’s behind it
- Introduced in HouseJan 9, 2023
- Jan 9, 2023IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Jan 9, 2023Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jan 9, 2023IntroReferralIntro-H
Introduced in House
- Jan 9, 2023IntroReferral1000
Introduced in House